Table 4.
KD subjects enrolled in this study
| Subjects | Age (yrs) | Sex | Illness day at diagnosis | Illnessday at phlebotomy | Zmaxa | WBC (103/μL) | Hgb (g/dL) | Neutrophils (%) | Bands (%) | ESR (mm/h) | CRP (mg/dL) | ALT (IU/L) | GGT (IU/L) | Aboslute lymphocyte count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 | 1.4 | F | 4 | 7 | 2.49 | 12.5 | 11 | 43 | 33 | 65 | 19.4 | 87 | 53 | 1750 |
| 29 | 5.8 | F | 5 | 6 | 0.6 | 9.6 | 9.9 | 58 | 7 | 8 | 8.3 | 23 | 55 | 2400 |
| 30 | 1.9 | F | 7 | 7 | 2.97 | 19.3 | 9.7 | 52 | 21 | 77 | 33.4 | 27 | 108 | 3281 |
| 31 | 1.9 | F | 7 | 7 | 2.69 | 16.7 | 10 | 65 | 14 | 127 | 14.4 | 48 | 29 | 2171 |
| 32 | 8.8 | M | 4 | 36 | 1.78 | 7.6 | 11.5 | 33 | 63 | 32 | 4.4 | 139 | 121 | 152 |
| 33 | 3.0 | F | 7 | 26 | 1.7 | 19.2 | 10.1 | 65 | 3 | 61 | 4.5 | 67 | 28 | 4608 |
| 34 | 7.1 | M | 3 | 27 | 0.1 | 15.4 | 13.3 | 51 | 19 | 34 | 6.1 | 104 | 98 | 1078 |
| 35 | 8.9 | M | 10 | 29 | 1.46 | 9.9 | 12 | 58 | 0 | 38 | 3.1 | 13 | 18 | 3564 |
| 36 | 6.6 | F | 4 | 46 | 1.07 | 18.3 | 12.4 | 74 | 3 | 30 | 2.5 | 113 | 170 | 1830 |
| 37 | 5.6 | F | 6 | 43 | 1.5 | 17.5 | 12.5 | 73 | 6 | 75 | 3.4 | 204 | 161 | 1750 |
| 38 | 7.0 | M | 16 | 38 | 2.02 | 15.6 | 10.5 | 69 | 3 | 58 | 4.4 | 93 | 656 | 1248 |
| 39 | 9.1 | M | 4 | 18 | 0.15 | 18 | 12.1 | 78 | 1 | 66 | 6.3 | 333 | 365 | 1800 |
| 40 | 9.1 | M | 5 | 27 | 1.33 | 7.8 | 12.4 | 53 | 2 | 47 | 0.6 | 80 | 145 | 3042 |
| 41 | 4.2 | F | 7 | 22 | 0.57 | 14.2 | 11.3 | 79.1 | NA | 53 | 22 | 197 | 235 | 1349 |
| 42 | 6.1 | F | 6 | 22 | 2.91 | 17.7 | 11.6 | 17 | 78 | 140 | 19.4 | 140 | 148 | 885 |
| 43 | 8.1 | M | 7 | 23 | 2.03 | 11.8 | 12.5 | 68 | 15 | 32 | 2.9 | 226 | 362 | 354 |
| 44 | 3.5 | M | 6 | 36 | 0.81 | 15.5 | 10.5 | 71 | 9 | 56 | 19.2 | 157 | 72 | 1705 |
| 45 | 2.3 | M | 11 | 15 | 3.12 | 11 | 10.8 | 63.3 | NA | 76 | 7.6 | 15 | 11 | 2453 |
aZmax: maximum Z score (internal diameter normalized for body surface area) for the right and left anterior descending coronary arteries.
bLaboratory data are pretreatment.
Abbreviations: ALC, absolute lymphocyte count; ALT, alanine aminotransferase; CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; GGT, gamma‐glutamyl transferase; Hgb, hemoglobin; WBC, white blood cell count; NA, not available.
Subjects 28–32 and 38–45 were sampled before the pandemic. Subjects 33–37 were sampled during the pandemic but had negative antibody and nucleic acid testing for SARS‐CoV‐2 at the time of phlebotomy.